Tionlab Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$4.27M
- Investors
-
12
Tionlab Therapeutics General Information
Description
Developer of a drug delivery system designed for patients suffering from diabetes and cancer. The company develops injections that can be used to deliver drugs with the frequency of one injection per month, enabling healthcare companies to provide patients with a convenient way to consume medicines for various diseases.
Contact Information
Website
www.tionlabrx.comCorporate Office
- 1910, U-TOWER, 120, Heungdeokjungang-ro
- Giheung-gu
- Yongin, Gyeonggi 16950
- South Korea
Corporate Office
- 1910, U-TOWER, 120, Heungdeokjungang-ro
- Giheung-gu
- Yongin, Gyeonggi 16950
- South Korea
Tionlab Therapeutics Timeline
Tionlab Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series A) | 31-Aug-2026 | $4.27M | Completed | Pre-Clinical Trials | ||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Accelerator/Incubator | 20-Jul-2023 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 04-Jun-2022 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jun-2022 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 26-Jul-2021 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Tionlab Therapeutics Patents
Tionlab Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025165146-A1 | Depot composition with controlled initial release through hydrophobic ion pairing gelation for treatment of obesity and diabetes for providing improved medical therapy of semaglutide or tirzepatide, and method for preparing same | Pending | 29-Jan-2024 | ||
| WO-2025150966-A1 | Sustained-release lipid pre-concentrate comprising sorbitan saturated fatty acid and method for preparing same | Inactive | 12-Jan-2024 | ||
| EP-4470524-A1 | Lipid fusion depot composition with controlled initial release, and method for preparing same | Pending | 27-Jan-2022 | ||
| EP-4470524-A4 | Lipid fusion depot composition with controlled initial release, and method for preparing same | Pending | 27-Jan-2022 | ||
| US-20260041636-A1 | Lipid fusion depot composition with controlled initial release, and method for preparing same | Pending | 27-Jan-2022 | A61K9/1271 |
Tionlab Therapeutics Signals
Tionlab Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Series Ventures | Venture Capital | Minority | ||
| Glitchor Partners | Accelerator/Incubator | Minority | ||
| Tech Incubator Program for Startup | Accelerator/Incubator | Minority | ||
| Korea Credit Guarantee Fund | Venture Capital | Minority | ||
| Shinhan Square Bridge | Accelerator/Incubator |
Tionlab Therapeutics FAQs
-
When was Tionlab Therapeutics founded?
Tionlab Therapeutics was founded in 2021.
-
Where is Tionlab Therapeutics headquartered?
Tionlab Therapeutics is headquartered in Yongin, South Korea.
-
What is the size of Tionlab Therapeutics?
Tionlab Therapeutics has 10 total employees.
-
What industry is Tionlab Therapeutics in?
Tionlab Therapeutics’s primary industry is Drug Delivery.
-
Is Tionlab Therapeutics a private or public company?
Tionlab Therapeutics is a Private company.
-
What is Tionlab Therapeutics’s current revenue?
The current revenue for Tionlab Therapeutics is .
-
How much funding has Tionlab Therapeutics raised over time?
Tionlab Therapeutics has raised $4.27M.
-
Who are Tionlab Therapeutics’s investors?
Series Ventures, Glitchor Partners, Tech Incubator Program for Startup, Korea Credit Guarantee Fund, and Shinhan Square Bridge are 5 of 12 investors who have invested in Tionlab Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process